|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquired_by
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:acquisition
|
€ 1.75 billion
|
|
gptkbp:acquisition_year
|
gptkb:2011
|
|
gptkbp:ceo
|
gptkb:Jaap_Goudsmit
gptkb:Ron_Cohen
|
|
gptkbp:clinical_trial
|
Phase II
Phase III
Phase I
|
|
gptkbp:employees
|
~ 500
|
|
gptkbp:founded
|
gptkb:1993
|
|
gptkbp:founder
|
gptkb:Jaap_Goudsmit
|
|
gptkbp:headquarters
|
gptkb:Leiden,_Netherlands
Leiden
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Crucell
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:key_people
|
gptkb:Johan_van_Hoof
gptkb:Ron_Cohen
|
|
gptkbp:location
|
gptkb:Europe
gptkb:North_America
|
|
gptkbp:notable_products
|
gptkb:HPV_vaccine
gptkb:Hepatitis_B_vaccine
gptkb:Zoster_vaccine
gptkb:Ebola_vaccine
gptkb:vaccine
gptkb:Malaria_vaccine
gptkb:PER._C6_cell_line
gptkb:Quinvaxem
gptkb:Rubella_vaccine
gptkb:Tuberculosis_vaccine
gptkb:Varicella_vaccine
Polio vaccine
Measles vaccine
Rotavirus vaccine
Influenza vaccine
Yellow fever vaccine
HIV vaccine
Cholera vaccine
Dengue vaccine
Nipah virus vaccine
Rabies vaccine
Typhoid vaccine
SARS vaccine
West Nile virus vaccine
Ad Vac technology
Meningitis vaccine
Pertussis vaccine
|
|
gptkbp:notable_work
|
monoclonal antibodies
viral vectors
|
|
gptkbp:partnership
|
gptkb:Astra_Zeneca
gptkb:Bristol-Myers_Squibb
gptkb:Merck_&_Co.
gptkb:Sanofi_Pasteur
gptkb:Glaxo_Smith_Kline
|
|
gptkbp:products
|
vaccines
therapeutics
|
|
gptkbp:research_focus
|
gptkb:Oncology
autoimmune diseases
infectious diseases
|
|
gptkbp:revenue
|
€ 200 million (2010)
|
|
gptkbp:subsidiary
|
gptkb:Crucell_Switzerland_AG
gptkb:Crucell_Holland_B._V.
|
|
gptkbp:website
|
www.crucell.com
|
|
gptkbp:bfsParent
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:bfsLayer
|
4
|